AU7-55

N/A

Report date: 2025/06/13 14:51:42
NME

Base Information

Drug NameAU7-55
Drug Alias NameAU7-55
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTYRO3 protein tyrosine kinase inhibitorsAXL receptor tyrosine kinase inhibitorsTyrosine-protein kinase Mer inhibitors
TargetsTYRO3 protein tyrosine kinaseAXL receptor tyrosine kinaseTyrosine-protein kinase Mer
Therapy Area/IndicationsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAucentra Therapeutics Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAucentra Therapeutics Pty Ltd
Inactive CompaniesN/A
Active IndicationsLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A